Distinguished Innovator Award

The Lupus Research Alliance Distinguished Innovator Award supports innovative research led by established investigators working on novel approaches to lupus treatment and understanding.

Program Focus:

• Supporting established researchers with innovative project proposals
• Funding research that may lead to new therapeutic targets and approaches
• Supporting diverse research areas within lupus science

Geographic Scope: United States and international (examples include researchers from Monash University in Australia and NYU School of Medicine)

Research Areas Funded:

• Type I interferon targeting and GILZ stimulation
• DNase1L3 enzyme therapy for lupus nephritis
• TLR8 protein targeting

Known Awardees:

• Eric Morand, PhD (Monash University, Australia) - GILZ targeting and type I interferon reduction
• Boris Reizis, PhD (NYU School of Medicine) - DNase1L3 enzyme research for lupus nephritis
• Mark Shlomchik, MD, PhD - T cell exhaustion in lupus (Lupus Insight Prize recipient)

Application Process

Detailed application procedures and submission requirements are not provided in the available website content. Prospective applicants should visit the Lupus Research Alliance website or contact the organization directly.

Contact for More Information:

• Lupus Research Alliance
• 52 Vanderbilt Ave, Suite 401, New York, NY 10017
• 646-884-6000
• Website: lupusresearch.org